Stockscreener 앱 받기
52.26
0.57%
-0.30
전일 마감가:
$52.56
열려 있는:
$51.8
하루 거래량:
342.84K
Relative Volume:
0.55
시가총액:
$2.48B
수익:
$1.10B
순이익/손실:
$186.50M
주가수익비율:
13.82
EPS:
3.7817
순현금흐름:
$267.19M
1주 성능:
-0.40%
1개월 성능:
+0.50%
6개월 성능:
-24.34%
1년 성능:
-21.71%
1일 변동 폭
$51.80
$52.58
1주일 범위
$51.08
$53.95
52주 변동 폭
$42.62
$71.07
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
명칭
Prestige Consumer Healthcare Inc
전화
(914) 524-6800
주소
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
52.26 | 2.39B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-24 | 업그레이드 | Sidoti | Neutral → Buy |
| 2024-12-09 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2024-06-21 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2022-11-17 | 개시 | Canaccord Genuity | Buy |
| 2022-05-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-05-09 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-08-07 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2020-06-29 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-04-14 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-04-07 | 재개 | Sidoti | Neutral |
| 2020-03-26 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-24 | 개시 | Oppenheimer | Perform |
| 2020-03-19 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2019-01-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | 업그레이드 | Jefferies | Underperform → Hold |
| 2017-05-22 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | 재확인 | B. Riley & Co. | Buy |
| 2016-11-17 | 개시 | Gabelli & Co | Buy |
| 2016-08-12 | 업그레이드 | Sidoti | Neutral → Buy |
| 2016-03-08 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | 개시 | Piper Jaffray | Overweight |
| 2015-11-30 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2014-04-28 | 재확인 | B. Riley & Co. | Buy |
| 2014-04-28 | 재확인 | Oppenheimer | Outperform |
| 2013-07-09 | 개시 | B. Riley & Co. | Buy |
모두보기
Prestige Consumer Healthcare Inc 주식(PBH)의 최신 뉴스
Clear Eyes Maximum Itchy Eye Relief Recall: FDA Announces 39,060 Bottles RecalledNews and Statistics - IndexBox
Nearly 40,000 eye drops recalled nationwide over possible contamination - Fox Business
Great Lakes Advisors LLC Takes $2.98 Million Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Clear Eyes eye drops recalled over sterility concerns - qz.com
FDA announces nationwide recall of nearly 40,000 Clear Eyes eye-drop bottles over potential contamination - The Economic Times
Is Prestige Consumer Healthcare’s (PBH) Upgraded 2027 Outlook and Halted Buybacks Reframing Its Growth Story? - webull.com
Rice Hall James & Associates LLC Acquires Shares of 689,692 Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript - AOL.com
Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 31.96% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Prestige Consumer Healthcare (PBH) Holds Near $51.38 as Range-Bound Trading PersistsVolume Dry Up - Vinanet
ETFs Investing in Prestige Consumer Healthcare Inc Stocks - TradingView
Prestige Consumer Healthcare Announces Operations Leadership Transition - The Globe and Mail
Prestige Consumer Healthcare's Jeffrey Zerillo to Retire as SVP, Operations - TradingView
Prestige Consumer Healthcare Inc. Announces Retirement of Jeffrey Zerillo from Senior Vice President, Operations, Effective August 14, 2026 - marketscreener.com
Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover? - Yahoo Finance
Prestige Consumer Healthcare at Canaccord Genuity: growth bets build By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare at Canaccord Genuity: growth bets build - Investing.com
Prestige Consumer Healthcare (NYSE:PBH) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Understanding Momentum Shifts in (PBH) - Stock Traders Daily
PBH: Deals Increase Sales Base by More than 20% - Smartkarma
Renaissance Technologies LLC Has $2.17 Million Stake in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Quantinno Capital Management LP Acquires 19,281 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference - The Manila Times
Prestige Consumer Executives Set for Aug. 12 Fireside Chat - Stock Titan
Prestige Consumer Healthcare In (PBH) Stock Forecasts - Yahoo! Finance Canada
Prestige Consumer Healthcare (PBH): Analyst Ratings and Growth Potential Offer 23% Upside for Investors - DirectorsTalk Interviews
Prestige Consumer Healthcare (PBH) Is Up 5.6% After Raising Fiscal 2027 Outlook on Acquisitions - Sahm
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein - The National Law Review
Prestige Consumer Healthcare In (PBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Prestige Consumer Healthcare Q1 Earnings Call Highlights - TradingView
Prestige Consumer Healthcare (NYSE:PBH) Issues Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
Prestige Consumer Healthcare (PBH) Stock Faces Margin Questions Despite Record Cash Flow - webull.com
Prestige Consumer Healthcare (PBH) Is Up 9.2% After Raising 2027 Outlook On Recent Acquisitions - Yahoo Finance
Prestige Consumer Healthcare Inc. $PBH Shares Bought by First Trust Advisors LP - MarketBeat
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $72 - Moomoo
Prestige Consumer Healthcare Inc (PBH) Stock News Today - TradingKey
PBH Stock Up on Q1 Earnings and Revenue Beat, Fiscal '27 View Raised - cnhinews.com
Prestige Consumer Healthcare Stock (PBH) Opinions on Recent Earnings and M&A Activity - Quiver Quantitative
Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF) and Prestige Consumer Healthcare (PBH) - The Globe and Mail
Prestige Consumer Healthcare Lifts Outlook on Acquisition-Driven Growth - The Globe and Mail
Prestige Consumer Healthcare Inc (PBH) (Q1 2027) Earnings Call H - GuruFocus
Earnings call transcript: Prestige Consumer beats Q1 2026 estimates as stock edges higher - Investing.com
Prestige Consumer Healthcare Inc (PBH) (Q1 2027) Earnings Call Highlights: Record Cash Flow and ... - Yahoo! Finance Canada
PBH Looks 23.2% Undervalued on GF Value™ - GuruFocus
Prestige Consumer Healthcare Inc. 2027 Q1ResultsEarnings Call Presentation (NYSE:PBH) 2026-08-06 - Seeking Alpha
Prestige Consumer Healthcare Shares Rise After Fiscal Q1 Beat, Fiscal 2027 Outlook Lifted - marketscreener.com
Is Prestige Consumer Healthcare Inc (PBH) Undervalued at 23.2% A - GuruFocus
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Prestige Consumer Healthcare (NYSE:PBH) Releases FY 2027 Earnings Guidance - MarketBeat
Prestige Consumer Healthcare Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
Prestige Consumer Healthcare Inc (PBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Prestige Consumer Healthcare Inc 주식 (PBH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Zerillo Jeffrey | Senior VP Operations |
May 07 '26 |
Sale |
54.36 |
305 |
16,580 |
42,161 |
1.66%
0.33%
자본화:
|
볼륨(24시간):